What is the NOAEL for 4-Hydroxybenzoic acid?
4-Hydroxybenzoic acid has 39 NOAEL studies in the database. The lowest reported value is -0.3 % via Dermal. Source: NTP_ICE_skin_sensitization.
Also known as: p-Hydroxybenzoic acid, 4-Carboxyphenol, EINECS 202-804-9, Acido p-idrossibenzoico, Kyselina 4-hydroxybenzoova (+10 more)
CAS 99-96-7
4-Hydroxybenzoic acid (CAS 99-96-7) is a chemical substance. Key regulatory status: REACH registered, 11 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH.
4-Hydroxybenzoic acid is classified GHS Danger (H315, H318, H319, H335) in the chemicals database but is restricted in EU cosmetics at max 0.4% (as acid) single; 0.8% mixtures (Annex V/12). Propyl/butylparaben sum ≤0.14%.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Europe; Personal care | European Commission | CosIng |
| consumer_product; Europe | Danish Environmental Protection Agency | Danish EPA |
| consumer_product; Europe | Danish Environmental Protection Agency | Danish EPA |
| Europe | European Commission | Fl@vis |
| children; WA Children's Safe Product Act (4/2020) | State of Washington Department of Ecology | State of Washington |
| food_additive; Substances Added to Food (formerly EAFUS) (2/2019) | FDA | United States Food and Drug Administration (FDA) |
| Canada; pharmaceutical | DrugBank | DrugBank |
| active_ingredient; Europe; Pesticides | European Commission | CPCat |
| children | Vermont Department of Health | State of Vermont |
| children | Maine Department of Environmental Protection | State of Maine |
| children | Oregon Health Authority | State of Oregon |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 1052 | ug/mL | CD54, EC200 | Dermal | - | NTP_ICE_skin_sensitization |
| >966.854 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| <1000 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| 1666.7 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| =4.8 | mg/m3 | DNEL local | inhalation | Human | ToxValDB_GESTIS_DNEL |
| =2.4 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| -0.3 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 1.7 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 3 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| -0.1 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 0.7 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 2.2 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 0.9 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 1.1 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 1.85 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| >2000 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| JG8Z55Y12H | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| JG8Z55Y12H | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| JG8Z55Y12H | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| JG8Z55Y12H | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| >2400 | uM | IC50 | Dermal | - | NTP_ICE_skin_sensitization |
| 1.064 | ratio | Imax | Dermal | - | NTP_ICE_skin_sensitization |
| 1.1 | ratio | Imax | Dermal | - | NTP_ICE_skin_sensitization |
| 1.146 | ratio | Imax | Dermal | - | NTP_ICE_skin_sensitization |
| 1.31 | ratio | Imax | Dermal | - | NTP_ICE_skin_sensitization |
| >2000 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =5000 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| >10000 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =5 | mg/kg bw/day | LEL | injection | Mouse | ToxValDB_Uterotrophic_Hershberger_DB |
| =200 | mg/kg bw/day | LOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =1000 | mg/kg bw/day | LOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| - | unitless | Model Score | - | - | NTP_ICE_endocrine |
| =1043 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =40 | mg/kg bw/day | NOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =60 | mg/m3 | NOEL | inhalation | Rat | ToxValDB_ECHA_IUCLID |
| >=100 | mg/kg bw/day | NOEL | injection | Mouse | ToxValDB_ECHA_IUCLID |
| >200 | mg/kg bw/day | NOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| >1000 | mg/kg bw/day | NOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| >=1030 | mg/kg bw/day | NOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
Showing 39 of 39 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | 4-hydroxybenzoic acid | 202-804-9 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Same-CAS food additive, ADI, and GRAS records where available.
ADI: No safety concern at current levels of intake when used as a flavouring agent mg/kg bw
View full food safety profile →Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →4-Hydroxybenzoic acid has 39 NOAEL studies in the database. The lowest reported value is -0.3 % via Dermal. Source: NTP_ICE_skin_sensitization.
4-Hydroxybenzoic acid appears on 8 regulatory/inventory lists including Europe; Personal care, consumer_product; Europe, Europe, and 5 more. Source: EPA CPDat.
Yes, 4-Hydroxybenzoic acid is also indexed as a cosmetic ingredient under the name 4-Hydroxybenzoic Acid. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed, EFSA / FDA GRAS, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
4-Hydroxybenzoic acid is classified GHS Danger (H315, H318, H319, H335) in the chemicals database but is restricted in EU cosmetics at max 0.4% (as acid) single; 0.8% mixtures (Annex V/12). Propyl/butylparaben sum ≤0.14%.
4-Hydroxybenzoic acid also appears in cosmetics, pharmaceutical, food safety, cannabis databases.